# Clinical Significance of Germline BRCA Mutations

> **NCT00579488** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 13320 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00579488
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 1996-07
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 13320 (ACTUAL)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00579488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00579488, "Clinical Significance of Germline BRCA Mutations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00579488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*